middle.news
EVE Health Launches Dyspro™ with First Commercial Order in $20B Dysmenorrhoea Market
8:58am on Monday 7th of July, 2025 AEST
•
Healthcare
Read Story
EVE Health Launches Dyspro™ with First Commercial Order in $20B Dysmenorrhoea Market
8:58am on Monday 7th of July, 2025 AEST
Key Points
First commercial purchase order submitted for Dyspro™
Manufacturing underway at GMP-certified Australian facility
Regulatory approvals and prescriber network in place for swift launch
Partnership with TeleDocs Clinic to support telehealth distribution
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Eve Health (ASX:EVE)
OPEN ARTICLE